Atorvastatin (Lipitor) Dosing Guidelines
The recommended starting dose of atorvastatin (Lipitor) is 10-20 mg once daily, with a dosage range of 10-80 mg once daily, taken at any time of day with or without food. 1
Standard Dosing Recommendations
Atorvastatin dosing should be based on the required LDL-cholesterol reduction and cardiovascular risk:
Initial dosing:
Dosage range: 10-80 mg once daily 1
Dosing by intensity:
Dosing Based on Patient Population
Adults with Cardiovascular Risk
- Primary prevention: 10-20 mg daily for moderate-intensity therapy in adults >40 years with diabetes or elevated ASCVD risk 2
- Secondary prevention: 40-80 mg daily (high-intensity) for patients with established ASCVD 2
Special Populations
- Pediatric patients (10 years and older) with heterozygous familial hypercholesterolemia: 10-20 mg once daily 1
- Pediatric patients (10 years and older) with homozygous familial hypercholesterolemia: 10-80 mg once daily 1
- Elderly patients (>75 years): Consider starting with moderate-intensity therapy (10-20 mg) 3
- Asian patients: May achieve similar LDL-C reductions at lower doses 3
Monitoring and Dose Adjustments
- Assess LDL-C levels 4-12 weeks after initiating therapy to evaluate response 3, 1
- Adjust dosage if necessary based on LDL-C response and tolerability 1
- For patients not achieving target LDL-C levels:
- Consider uptitration to next dose level if tolerated
- For very high-risk patients with LDL-C ≥70 mg/dL despite maximum tolerated statin therapy, consider adding ezetimibe 3
Drug Interactions Requiring Dose Adjustments
Anti-viral medications:
Azole antifungals or macrolide antibiotics:
- With clarithromycin or itraconazole: Do not exceed 20 mg daily 1
Contraindications
- Acute liver failure or decompensated cirrhosis 1
- Hypersensitivity to atorvastatin or any excipients 1
Important Considerations
- If a dose is missed, patients should not take the missed dose and should resume with the next scheduled dose 1
- Monitor for signs of myopathy and rhabdomyolysis, particularly when using high-intensity dosing 1
- Risk of new-onset diabetes is increased with high-intensity statin therapy (36% relative increase compared to placebo), particularly in patients with risk factors for diabetes 2
By following these evidence-based dosing recommendations, clinicians can optimize the cardiovascular benefits of atorvastatin while minimizing potential adverse effects.